MCID: DMN031
MIFTS: 60

Dementia, Lewy Body malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Mental diseases

Aliases & Classifications for Dementia, Lewy Body

About this section

Aliases & Descriptions for Dementia, Lewy Body:

Name: Dementia, Lewy Body 51 24 12
Lewy Body Dementia 51 11 47 24 48 69 13
Lewy Body Disease 11 47 26 49 37 38 67
Diffuse Lewy Body Disease 11 47 24 69
Dementia with Lewy Bodies 11 48 13
Dlb 47 24 69
Autosomal Dominant Diffuse Lewy Body Disease 47 67
 
Dementia Lewy Body 69 26
Diffuse Lewy Body Disease with Gaze Palsy 69
Lewy Body Variant of Alzheimer Disease 69
Senile Dementia of the Lewy Body Type 11
Lewy Body Type Senile Dementia 69
Dysphasic Dementia Hereditary 69
Cortical Lewy Body Disease 69

Characteristics:

HPO:

63
dementia, lewy body:
Inheritance: autosomal dominant inheritance

Classifications:



External Ids:

OMIM51 127750
Disease Ontology11 DOID:12217
ICD1029 G31.83
ICD9CM31 331.82
MeSH38 D020961
NCIt44 C84826

Summaries for Dementia, Lewy Body

About this section
MedlinePlus:37 Lewy body disease is one of the most common causes of dementia in the elderly. dementia is the loss of mental functions severe enough to affect normal activities and relationships. lewy body disease happens when abnormal structures, called lewy bodies, build up in areas of the brain. the disease may cause a wide range of symptoms, including changes in alertness and attention hallucinations problems with movement and posture muscle stiffness confusion loss of memory lewy body disease can be hard to diagnose, because parkinson's disease and alzheimer's disease cause similar symptoms. scientists think that lewy body disease might be related to these diseases, or that they sometimes happen together. lewy body disease usually begins between the ages of 50 and 85. the disease gets worse over time. there is no cure. treatment focuses on drugs to help symptoms. nih: national institute of neurological disorders and stroke

MalaCards based summary: Dementia, Lewy Body, also known as lewy body dementia, is related to corticobasal degeneration and multiple system atrophy, and has symptoms including hallucinations, hypertonia and sudden cardiac death. An important gene associated with Dementia, Lewy Body is SNCA (Synuclein Alpha), and among its related pathways are Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction) and Dopamine metabolism. Affiliated tissues include brain, skin and eye, and related mouse phenotypes are muscle and taste/olfaction.

Disease Ontology:11 A dementia and a synucleinopathy that is characterized by the development of abnormal proteinaceous (alpha-synuclein) cytoplasmic inclusions, called Lewy bodies, throughout the brain that results in progressive decline in mental abilities.

UniProtKB/Swiss-Prot:69 Dementia Lewy body: A neurodegenerative disorder characterized by mental impairment leading to dementia, parkinsonism, fluctuating cognitive function, visual hallucinations, falls, syncopal episodes, and sensitivity to neuroleptic medication. Brainstem or cortical intraneuronal accumulations of aggregated proteins (Lewy bodies) are the only essential pathologic features. Patients may also have hippocampal and neocortical senile plaques, sometimes in sufficient number to fulfill the diagnostic criteria for Alzheimer disease.

NINDS:48 Dementia with Lewy bodies (DLB)

OMIM:51 Dementia with Lewy bodies (DLB) is a neurodegenerative disorder clinically characterized by dementia and parkinsonism,... (127750) more...

NIH Rare Diseases:47 Lewy body dementia is one of the most common forms of progressive dementia. People affected by this condition may experience a variety of symptoms such as changes in alertness and attention; hallucinations; problems with movement and posture; muscle stiffness; confusion; and/or memory loss. Although the exact cause of Lewy body dementia is poorly understood, symptoms are thought to result when clumps of a protein called alpha-synuclein (Lewy bodies) accumulate in the brain. Lewy body dementia usually occurs sporadically in people with no family history of the condition. Rarely, more than one family member may be affected. There is currently no cure for Lewy body dementia; however, medications may be available to help manage the associated symptoms. Last updated: 11/5/2015

Wikipedia:70 Dementia with Lewy bodies (DLB) is a type of dementia that worsens over time. Additional symptoms may... more...

Related Diseases for Dementia, Lewy Body

About this section

Diseases related to Dementia, Lewy Body via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 62)
idRelated DiseaseScoreTop Affiliating Genes
1corticobasal degeneration11.3
2multiple system atrophy11.3
3postinfectious vasculitis10.7APOE, MAPT
4angelman syndrome due to imprinting defect in 15q11-q1310.7GBA, LRRK2, SNCA
5braddock jones superneau syndrome10.7SNCA, TH
6testicular seminoma10.6APOE, MAPT
7adult brain stem glioma10.5MAPT, SLC6A3, SNCA
8glucose transporter type 1 deficiency syndrome10.5APOE, PRNP
9suppurative thyroiditis10.5MAOB, MAPT, SNCA
10atrial septal defect 910.5APP, MAPT, SNCA
11parkinson disease 6, early onset10.5LRRK2, PARK2, PARK7
12klippel-feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism10.5PARK2, PARK7, SNCA
13basilar impression, primary10.4MAPT, RPS27A, SNCA
14essential tremor10.4LRRK2, PARK2, SLC6A3, SNCA
15hemiplegia alterans10.4APOE, SNCA
16parkinson disease 14, autosomal recessive10.4APP, RPS27A
17epileptic hemiplegia10.4PARK2, SNCA
18parkinson disease 1010.4LRRK2, PARK2, PARK7, SNCA
19gingival disease10.4MAPT, RPS27A, TH
20celiac disease 1210.4LRRK2, PARK2, PARK7, SNCA
21epilepsy, progressive myoclonic 1b10.4LRRK2, PARK2, PARK7, SNCA
22hypogonadism cardiomyopathy10.4ACHE, TH
23whiplash10.4GBA, LRRK2, MAPT, PARK2, SNCA
24nosophobia10.4APOE, LRRK2, MAPT, PRNP
25anaerobic pneumonia10.4APOE, APP, BCHE, MAPT
26bladder mixed adenocarcinoma10.4MAOB, SLC18A2, SLC6A3, SNCA
27polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract10.3APOE, APP, PRNP
28cardiomyopathy, dilated, 1u10.3APOE, MAPT, RPS27A, SNCA
29purpura10.3MAOB, SLC18A2, TH
30prion disease with protracted course10.3APOE, MAPT, PRNP
31acrofrontofacionasal dysostosis10.3ACHE, BCHE, MAPT, PRNP
32perry syndrome10.3MAPT, SLC18A2, SLC6A3, SNCA, TH
33intravascular angioleiomyoma10.3APOE, APP
34allergic bronchopulmonary aspergillosis, familial10.3APOE, APP, MAPT, RPS27A
35microsporidiosis10.2APOE, GBA, MAPT, PRNP, SLC6A3
36anti-p200 pemphigoid10.2APOE, LRRK2, MAPT, RPS27A, SNCA
37dementia10.2
38narcolepsy 210.2MAOB, SLC18A2, SLC6A3, SNCA
39gemistocytic astrocytoma10.2APOE, APP, MAPT, PRNP, SNCA
40erythematosquamous dermatosis10.2ACHE, LRRK2, RPS27A, SLC6A3, SNCA
41phka2-related phosphorylase kinase deficiency10.2GBA, LRRK2, MAPT, PARK2, PARK7, SNCA
42coenzyme q10 deficiency, primary, 110.0MAOB, PARK2, PARK7, SLC18A2, SNCA, SNCAIP
43craniosynostosis, adelaide type10.0CYP2D6, MAOB, SLC18A2, SLC6A3, TH
44idiopathic neonatal atrial flutter10.0CYP2D6, MAOB
45ovarian mucinous cystadenocarcinoma10.0MAOB, PRNP, SLC18A2, SLC6A3, SNCA, TH
46avoidant personality disorder9.9ADAMTS2, APOE, CYP2D6, MAPT, SLC6A3, SNCA
47alzheimer disease9.9
48mast syndrome9.8APP, LRRK2, MAPT, PARK2, PARK7, RPS27A
49tinea unguium9.8APOE, APP, GBA, MAPT, PARK2, PRNP
50polycystic kidney disease 29.8LRRK2, MAPT, PARK2, RPS27A, SLC6A3, SNCA

Graphical network of the top 20 diseases related to Dementia, Lewy Body:



Diseases related to dementia, lewy body

Symptoms for Dementia, Lewy Body

About this section

Symptoms by clinical synopsis from OMIM:

127750

Clinical features from OMIM:

127750

Human phenotypes related to Dementia, Lewy Body:

 63 (show all 23)
id Description HPO Frequency HPO Source Accession
1 hallucinations63 hallmark (90%) HP:0000738
2 hypertonia63 hallmark (90%) HP:0001276
3 sudden cardiac death63 hallmark (90%) HP:0001645
4 abnormality of extrapyramidal motor function63 hallmark (90%) HP:0002071
5 abnormality of the autonomic nervous system63 hallmark (90%) HP:0002270
6 eeg abnormality63 hallmark (90%) HP:0002353
7 sleep disturbance63 hallmark (90%) HP:0002360
8 developmental regression63 hallmark (90%) HP:0002376
9 hypotension63 hallmark (90%) HP:0002615
10 gait disturbance63 typical (50%) HP:0001288
11 neurological speech impairment63 typical (50%) HP:0002167
12 incoordination63 typical (50%) HP:0002311
13 tremor63 occasional (7.5%) HP:0001337
14 restrictive ventilatory defect63 occasional (7.5%) HP:0002091
15 involuntary movements63 occasional (7.5%) HP:0004305
16 abnormality of the sense of smell63 occasional (7.5%) HP:0004408
17 feeding difficulties in infancy63 occasional (7.5%) HP:0008872
18 skin ulcer63 occasional (7.5%) HP:0200042
19 dementia63 HP:0000726
20 delusions63 HP:0000746
21 parkinsonism63 HP:0001300
22 visual hallucinations63 HP:0002367
23 fluctuations in consciousness63 HP:0007159

UMLS symptoms related to Dementia, Lewy Body:


back pain, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, hallucinations, visual, vertigo/dizziness, sleeplessness

Drugs & Therapeutics for Dementia, Lewy Body

About this section

Drugs for Dementia, Lewy Body (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 76)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Armodafinilapproved, investigationalPhase 4195112111-43-0
Synonyms:
 
(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
R-modafinil
2
Modafinilapproved, investigationalPhase 419568693-11-84236
Synonyms:
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
Modafinilo [Spanish]
 
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
3
DonepezilapprovedPhase 4, Phase 3, Phase 2280120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
4
Buprenorphineapproved, illicit, investigational, vet_approvedPhase 439752485-79-740400, 644073
Synonyms:
(-)-Buprenorphine
(-)-buprenorphine
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-(methyloxy)-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
(−)-buprenorphine
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-7alpha-yl)-3,3-dimethyl-2-butanol
2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-(Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
52485-79-7
53152-21-9 (hydrochloride)
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-,
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)- (9CI)
6029-M
AC1L23NL
AC1L9B1M
AC1LD8IH
Buprel
Buprenex
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
 
Buprenorphine (JAN/INN)
Buprenorphine Hcl
Buprenorphine [INN:BAN]
Buprenorphinum
Buprenorphinum [INN-Latin]
C08007
C29H41NO4
CHEBI:3216
CHEMBL1201894
CHEMBL47085
CID40400
CID441363
CID5311033
CID6321408
CID644073
D07132
DB00921
DEA No. 9064
EINECS 257-950-6
LS-67682
MolPort-004-285-844
PDSP2_000111
Probuphine
RX 6029M
RX-6029-M
Subutex
Temgesic
Temgesic (TN)
UNII-40D3SCR4GZ
[5alpha,7alpha(S)]-17-(Cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol
buprenorphine
5
AcetaminophenapprovedPhase 4978103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
6
DopamineapprovedPhase 4, Phase 3, Phase 2, Phase 1375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
7
Memantineapproved, investigationalPhase 4, Phase 217619982-08-24054
Synonyms:
1,3-Dimethyl-5-adamantanamine
1-Amino-3,5-dimethyladamantane
19982-08-2
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyladamantan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
BBL000737
BPBio1_001117
BPBio1_001270
BSPBio_001015
Biomol-NT_000209
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DMAA
DivK1c_000068
EU-0053634
Ebixa
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
 
KBio2_006223
KBio3_001926
KBioGR_001543
KBioSS_001087
LS-157051
Lopac0_000861
Memantin
Memantina
Memantina [INN-Spanish]
Memantine
Memantine (INN)
Memantine HCL
Memantine Hydrochloride
Memantine [INN:BAN]
Memantine [INN]
Memantinum
Memantinum [INN-Latin]
MolPort-002-041-858
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Namenda
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
ST057652
STK520682
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
Spectrum_000607
UNII-W8O17SJF3T
ZERO/006024
memantine
8Cytochrome P-450 CYP3A InducersPhase 41101
9Nootropic AgentsPhase 4, Phase 3, Phase 2701
10Wakefulness-Promoting AgentsPhase 4192
11Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
12Cholinesterase InhibitorsPhase 4, Phase 3, Phase 2570
13Cholinergic AgentsPhase 4, Phase 3, Phase 2, Phase 13846
14Central Nervous System StimulantsPhase 42132
15Narcotic AntagonistsPhase 4906
16Central Nervous System DepressantsPhase 412806
17AntipyreticsPhase 41534
18Analgesics, OpioidPhase 43091
19Peripheral Nervous System AgentsPhase 4, Phase 322776
20Analgesics, Non-NarcoticPhase 46260
21NarcoticsPhase 43486
22AnalgesicsPhase 411287
23Excitatory Amino AcidsPhase 4, Phase 21297
24Antiparkinson AgentsPhase 4, Phase 21527
25Dopamine AgentsPhase 4, Phase 3, Phase 2, Phase 13759
26Excitatory Amino Acid AntagonistsPhase 4, Phase 21282
27Pharmaceutical SolutionsPhase 47793
28Fluorodeoxyglucose F18Phase 4392
29
CorticosteronePhase 41150-22-65753
Synonyms:
11,21-Dihydroxypregn-4-ene-3,20-dione
11,21-Dihydroxyprogesterone
11-Hydroxycorticoaldosterone
 
17-Deoxycortisol
4-Pregnene-11 Corticosteron
Corticosterone
Kendall'S compound B
Reichstein'S substance H
30Anti-Inflammatory AgentsPhase 410355
31cadexomer iodinePhase 4514
32
IodinePhase 45467553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
33CalamusNutraceuticalPhase 4419
34
GalantamineapprovedPhase 3105357-70-09651, 908828, 9651
Synonyms:
(-)-Galanthamine
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol
1551-02-6
1953-04-4
1dx6
1qti
357-70-0
4-27-00-02184 (Beilstein Handbook Reference)
736-79-8
AC-20240
AC1L1TIM
BIDD:GT0517
BPBio1_000480
BRD-K49481516-004-03-5
BRD-K49481516-004-04-3
BRN 0093736
BSPBio_000436
BSPBio_003416
C08526
CHEBI:42944
CHEMBL659
CID9651
D04292
DivK1c_000590
GNT
Galantamin
Galantamina
Galantamina [INN-Spanish]
Galantamine
Galantamine (USAN/INN)
Galantamine [USAN:INN]
Galantaminum
Galantaminum [INN-Latin]
Galanthamine
Galanthamine hydrobromide
Galanthaminum
 
HMS2089H03
HSDB 7361
IDI1_000590
InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
Jilkon
KBio1_000590
KBio2_001751
KBio2_004319
KBio2_006887
KBio3_002636
KBioGR_001417
KBioSS_001751
LS-71039
Lycoremin
Lycoremine
MolPort-002-521-885
NCGC00024731-02
NINDS_000590
NSC 100058
Prestwick0_000588
Prestwick1_000588
Prestwick2_000588
Prestwick3_000588
Probes1_000055
Probes2_000395
Razadyne ER
Reminyl
Reminyl (TN)
SDCCGMLS-0066737.P001
SMP1_000131
SPBio_002655
STOCK1N-46108
Spectrum3_001738
Spectrum4_000839
Spectrum5_001673
Spectrum_001271
UNII-0D3Q044KCA
galanthamine
35Protective AgentsPhase 37190
36Dopamine agonistsPhase 2, Phase 3, Phase 1618
37Autonomic AgentsPhase 39774
38
QuinidineapprovedPhase 24456-54-2441074
Synonyms:
(+)-quinidine
(-)-Quinine
(8R,9S)-Quinidine
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
11010-73-4
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
21480-31-9
22600_FLUKA
22620_FLUKA
22620_SIGMA
50-54-4
500225-45-6
549-56-4
55980-20-6
56-54-2
572-59-8
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6119-70-6
6151-39-9
6151-40-2
6183-68-2
6591-63-5
6912-57-8
72646-90-3
767303-40-2
804-63-7
840482-04-4
845886-64-8
857212-53-4
864908-93-0
875538-34-4
882741-47-1
883881-01-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-00-1
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
910899-51-3
911445-75-5
918778-04-8
AB00514657
AC1L199L
AC1L1ANE
AC1L1LHL
AC1L1R7Y
AC1L3RNZ
AC1L9AHT
AC1L9AHW
AC1LCUGN
AC1LDI43
AC1LDI46
AC1MBNAI
AC1MHDEF
AC1MHUCH
AC1MHWS7
AC1MI1Q5
AC1NSV55
AC1NSV58
AC1NSZYR
AC1NSZYU
AC1NUNML
AC1NUNMO
AC1NX8JM
AC1O56R7
AC1O7EE0
AC1O7GNZ
AC1OAH7Z
AC1OCD5W
AC1OCD62
AC1OFCPL
AC1Q4EZ5
AC1Q4EZ6
AC1Q58AF
AR-1A4833
AR-1H2065
Aflukin
Apo-Quinidine
Auriquin
BB_NC-0697
BIB1110
BIDD:GT0144
Biquin Durules
C06526
C06527
C20H24N2O2
CCRIS 5755
CCRIS 672
CHEBI:111177
CHEBI:15854
CHEBI:28593
CHEMBL170
CHEMBL21578
CHEMBL576997
CHEMBL601807
CHEMBL97
CID10448938
CID1065
CID25522
CID2728270
CID3000825
CID3032576
CID3034034
CID3036746
CID441073
CID441074
CID5317111
CID5317112
CID5320867
CID5320868
 
CID5484444
CID5484450
CID5748152
CID5953
CID637552
CID6453100
CID6602154
CID6604605
CID667448
CID667449
CID6857801
CID6916033
CID6916036
CID7048767
CID8549
CID94175
CID9967055
CIN-QUIN
CPD000857275
Cardioquin
Chinidin
Chinidine
Chinidinum
Chinin
Chinine
Cin-Quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
D08458
D08460
DB00468
DB00908
Duraquin
Epiquinidine
FT-0082277
GNF-PF-5459
GNF-Pf-180
GNF-Pf-5423
HMS1304I22
HMS1607A11
HMS1989J09
HMS2089E05
HSDB 225
HSDB 2501
I14-3348
I14-3397
IBS-L0034250
IDI1_000134
KBio1_000134
KBio2_001392
KBio2_003960
KBio2_006528
KBio3_001551
KST-1A1085
Kinidin
Kinidin (TN)
L001278
LS-141252
LS-187236
LS-194958
LS-221
LS-4562
LT00645788
Lopac-Q-0875
Lopac-Q-1250
MLS001304041
MLS001335913
MLS001335914
NCI-C56246
NCI60_004320
NINDS_000134
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Novoquinidin
OR28880
Pitayin
Pitayine
Q0006
Q3625_SIGMA
Quin-Release
Quinact
Quinaglute
Quinaglute Dura-Tabs
Quinalan
Quinate
Quinatime
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
Quinidine
Quinidine Gluconate
Quinidine Sulfate
Quiniduran
Quinimax
Quinine
Quinine Dab
Quinora
Quniacridine
RH01857
SAM002264644
SB01652
SMP1_000254
SMR000718748
SMR000857275
SPBio_001375
SPBio_002379
ST056282
TCMDC-131239
TNP00086
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
beta-Quinine
bmse000511
chinidinum
chininum
quinidina
quinidine
quinina
β-quinine
39
DextromethorphanapprovedPhase 2129125-71-35360696, 5362449
Synonyms:
( )-3-Methoxy-N-methylmorphinon
( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren
(+)-3-Methoxy-17-methylmorphinan
(+)-dextromethorphan
(-)-3-Methoxy-N-methylmorphinan
(9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan
125-69-9 (hydrobromide)
125-70-2
125-71-3
18046-32-7
18609-21-7 (hydrochloride)
3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
3-Methoxy-17-methylmorphinan
32062-10-5
4-21-00-01367 (Beilstein Handbook Reference)
6700-34-1 (hydrobromide, mono-hydrate)
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI)
AC-13098
AC1L1EYT
Albutussin
Antussan
BA 2666
BPBio1_000503
BRD-K33211335-337-03-7
BRN 0088549
BSPBio_000457
Balminil DM
Balminil DM Children
Bayer Select Flu Relief
Bayer Select Head & Chest Cold
Bayer Select Night Time Cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM (TN)
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
C06947
CHEBI:128891
CHEBI:4470
CHEBI:580686
CHEMBL22207
CHEMBL52440
CID3008
CID5360696
CID5362449
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac Day & Night Cold/Flu Day Caplets
Contac Jr. Non-drowsy Formula
Contac Nighttime Cold Medicine
Contac Severe Cold Formula Maximum Strength
Contac Severe Cold Formula Non-Drowsy
Coricidin Syrup
Cosylan
Cough-X
Creo-Terpin
D-Methorphan
D-Methorphan Hydrobromide
D-methorphan
D03742
DB00514
DEA No. 9210
DM
DXM
Delsym
Delsym Cough Formula
Delta-Methorphan
Demorphan
Demorphan Hydrobromide
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [DCIT]
Destrometerfano [Dcit]
Dex
Dextromethorfan
Dextromethorfan [Czech]
Dextromethorphan
Dextromethorphan (USP)
Dextromethorphan Bromhydrate
Dextromethorphan Bromide
Dextromethorphan [USP:INN:BAN]
Dextromethorphan hydrobromide OROS Tablets
Dextromethorphan hydrobromide [BAN:JAN]
Dextromethorphan hydrobromide monohydrate
Dextromethorphane
Dextromethorphane [INN-French]
Dextromethorphanum
Dextromethorphanum [INN-Latin]
Dextrometorfano
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dextrométhorphane
Dexyromethorphan
Diabe-Tuss DM Syrup
 
Dimacol
Dimetapp DM
Dormetan
Dormethan
Drixoral Cough
Drixoral Cough & Congestion
Drixoral Cough & Sore Throat
EINECS 204-751-7
EINECS 204-752-2
Endotussin-NN
Endotussin-NN Pediatric
HMS2090C08
HSDB 3056
Hihustan M.
Hold
Hold DM
Koffex DM
L-Methorphan
LS-91837
LS-91838
Levomethorphan
Levomethorphan [BAN:DCF:INN]
Levomethorphan [Ban:Dcf:Inn]
Levomethorphan [INN:BAN:DCF]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
Lopac-D-2531
Lopac0_000337
MLS000758303
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
MolPort-003-940-943
MolPort-004-285-957
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI)
NCGC00015333-01
NCGC00015333-02
NCGC00015333-04
NCGC00162126-01
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex Severe Cold Formula
Orthoxicol
PediaCare 1
PediaCare Cough-Cold Formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick0_000359
Prestwick1_000359
Prestwick2_000359
Prestwick3_000359
Prestwick_686
RACEMETHORPHAN
Robitussin CF
Robitussin Cold & Cough
Robitussin Cough Calmers
Robitussin DM
Robitussin Maximum Strength Cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin Pediatric Cough
Robitussin Pediatric Cough & Cold
Robitussin Pediatric Cough Suppressant
Robitussin Pediatric Night Relief
Romilar
Rondec dm
Ru-Tuss Expectorant
SPBio_002378
St. Joseph Cough Syrup
Sucrets 4 Hour Cough Suppressant
Sudafed Cough Syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-Organidin
Tussi-Organidin DM NR
Tussi-Organidin DM-S NR
Tylenol Cold No Drowsiness
Tylenol Cold and Flu Multi-Symptom
Tylenol Cold and Flu No Drowsiness
Tylenol Cough + Decongestant Liquid
Tylenol Cough Liquid
Tylenol Flu No Drowsiness Gelcaps
UNII-7355X3ROTS
Vicks 44 Cough Relief
Viro-Med
d-Methorphan
delta-Methorphan
dextromethorphan
l-Methorphan
40DulaglutideapprovedPhase 242923950-08-7
41
Guaifenesinapproved, vet_approvedPhase 261693-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
42
MetforminapprovedPhase 21746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
43Quinidine gluconatePhase 244
44Hypoglycemic AgentsPhase 25733
45ImmunoglobulinsPhase 26045
46Immunoglobulin Fc FragmentsPhase 241
47Antitussive AgentsPhase 2520
48AntibodiesPhase 26045
49Chlorpheniramine, phenylpropanolamine drug combinationPhase 2616
50Respiratory System AgentsPhase 24818

Interventional clinical trials:

(show top 50)    (show all 97)
idNameStatusNCT IDPhase
1Efficacy of Pain Treatment on Depression in Patients With DementiaUnknown statusNCT02267057Phase 4
2"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"CompletedNCT01023672Phase 4
3Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT00855686Phase 4
4A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)RecruitingNCT02345213Phase 4
5DaTSCAN Imaging in Aging and Neurodegenerative DiseaseEnrolling by invitationNCT01453127Phase 4
6Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationNCT00950430Phase 4
7Evaluating the Effects of Music Interventions on Hospitalised People With DementiaUnknown statusNCT00448318Phase 2, Phase 3
8Donepezil Treatment of Psychotic Symptoms in Dementia PatientsUnknown statusNCT00190021Phase 3
9Safety and Efficacy of Galantamine in Patients With Dementia With Lewy BodiesCompletedNCT00230997Phase 3
10A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension PhaseCompletedNCT01278407Phase 3
11Oculomotor Testing in the Differential Diagnosis of DementiaCompletedNCT01577394Phase 3
12Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body DementiaCompletedNCT00209456Phase 3
13A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement DisordersCompletedNCT01550484Phase 2, Phase 3
14Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB ExtensionEnrolling by invitationNCT02928445Phase 2, Phase 3
15A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy BodiesCompletedNCT00598650Phase 2
16A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)CompletedNCT00543855Phase 2
17Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)CompletedNCT00630500Phase 2
18A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1, Phase 2
19Efficacy of 1072nm Infrared Stimulation on Executive Functioning in DementiaCompletedNCT01059877Phase 1, Phase 2
20Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy BodiesRecruitingNCT02702102Phase 2
21Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB StudyRecruitingNCT02669433Phase 2
22Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body DementiaRecruitingNCT02640729Phase 2
23Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia With Lewy BodiesRecruitingNCT02708186Phase 2
24Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaRecruitingNCT02910102Phase 2
25Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)RecruitingNCT02450786Phase 2
26Safety, Tolerability and Efficacy of AVP-786 for the Treatment of DisinhibitionRecruitingNCT02534038Phase 2
27A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyRecruitingNCT02973100Phase 2
28Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderEnrolling by invitationNCT02871427Phase 2
29Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's DiseaseNot yet recruitingNCT02954978Phase 2
30Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)Unknown statusNCT00674895Phase 1
31Nilotinib in Cognitively Impaired Parkinson Disease Patients 001CompletedNCT02281474Phase 1
32Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine MethodsCompletedNCT01003535Phase 1
33Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy BodiesRecruitingNCT01340001Phase 1
34Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.Unknown statusNCT01876459
35Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy BodiesUnknown statusNCT01256905
36Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))Unknown statusNCT01993628
37Study of MRI 3Tesla Infusion Without Arterial Spin Labeling Injection (ASL) in Cognitive Atypical and Comparison to the FDG-PETUnknown statusNCT02058043
38Glucose Tolerance in Patients With an Idiopathic Parkinson's DiseaseUnknown statusNCT01114321
39Melatonin for Circadian Sleep Disorders in the BlindUnknown statusNCT00911053
40Blind Adult Melatonin Treatment StudyUnknown statusNCT00686907
41Melatonin Studies of Totally Blind ChildrenUnknown statusNCT00795236
42Blind Child Melatonin Treatment StudyUnknown statusNCT00691444
43A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body DiseaseCompletedNCT01944436
44Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy BodiesCompletedNCT00917709
45Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's DiseaseCompletedNCT02268617
46Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)CompletedNCT00820937
47Deep Brain Stimulation for Patients With Dementia With Lewy BodiesCompletedNCT02263937
48Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)CompletedNCT00776347
49Research of Biomarkers in Parkinson DiseaseCompletedNCT00465790Early Phase 1
50Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?CompletedNCT00147693

Search NIH Clinical Center for Dementia, Lewy Body


Cochrane evidence based reviews: lewy body disease

Genetic Tests for Dementia, Lewy Body

About this section

Genetic tests related to Dementia, Lewy Body:

id Genetic test Affiliating Genes
1 Lewy Body Dementia26
2 Lewy Bodies26
3 Dementia, Lewy Body24 SNCA

Anatomical Context for Dementia, Lewy Body

About this section

MalaCards organs/tissues related to Dementia, Lewy Body:

35
Brain, Skin, Eye, Testes, Colon

Animal Models for Dementia, Lewy Body or affiliated genes

About this section

MGI Mouse Phenotypes related to Dementia, Lewy Body:

40 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.6ACHE, APOE, APP, MAPT, PARK2, PRNP
2MP:00053949.6APOE, MAPT, SLC18A2, SLC6A3, SNCA
3MP:00053889.6ACHE, ADAMTS2, APOE, GBA, LRRK2, PARK2
4MP:00030129.3ACHE, APOE, APP, LRRK2, MAPT, PARK2
5MP:00028739.2ADAMTS2, APP, GBA, LRRK2, MAPT, PRNP
6MP:00107719.1ADAMTS2, APOE, APP, GBA, LRRK2, MAPT
7MP:00053848.7APOE, APP, GBA, LRRK2, MAOB, MAPT
8MP:00107688.6ACHE, APOE, APP, BCHE, GBA, LRRK2
9MP:00053868.5ACHE, APOE, APP, GBA, LRRK2, MAOB
10MP:00053788.4ACHE, ADAMTS2, APOE, APP, GBA, MAPT
11MP:00036318.2ACHE, APOE, APP, GBA, LRRK2, MAOB
12MP:00053768.1ACHE, APOE, APP, BCHE, GBA, LRRK2

Publications for Dementia, Lewy Body

About this section

Articles related to Dementia, Lewy Body:

idTitleAuthorsYear
1
The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China. (26882509)
2016
2
Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer's disease with dementia Lewy bodies. (25848239)
2015
3
Parkinson's disease with dementia, lewy-body disorders and alpha-synuclein: recent advances and a case report. (21560084)
2011

Variations for Dementia, Lewy Body

About this section

UniProtKB/Swiss-Prot genetic disease variations for Dementia, Lewy Body:

69
id Symbol AA change Variation ID SNP ID
1SNCAp.Glu46LysVAR_022703rs104893875

Clinvar genetic disease variations for Dementia, Lewy Body:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SNCANM_000345.3(SNCA): c.136G> A (p.Glu46Lys)SNVPathogenicrs104893875GRCh37Chr 4, 90749321: 90749321
2SNCASNCA, DUPLICATIONduplicationPathogenicChr na, -1: -1
3GBANM_000157.3(GBA): c.1448T> C (p.Leu483Pro)SNV, CompoundHeterozygotePathogenic, risk factorrs421016GRCh37Chr 1, 155205043: 155205043
4GBANM_001005741.2(GBA): c.1226A> G (p.Asn409Ser)SNVPathogenic, risk factorrs76763715GRCh37Chr 1, 155205634: 155205634
5SNCBNM_001001502.2(SNCB): c.208G> A (p.Val70Met)SNVPathogenicrs104893936GRCh37Chr 5, 176053473: 176053473
6SNCBNM_001001502.2(SNCB): c.368C> A (p.Pro123His)SNVPathogenicrs104893937GRCh37Chr 5, 176048219: 176048219

Expression for genes affiliated with Dementia, Lewy Body

About this section
Search GEO for disease gene expression data for Dementia, Lewy Body.

Pathways for genes affiliated with Dementia, Lewy Body

About this section

Pathways related to Dementia, Lewy Body according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathwaysScoreTop Affiliating Genes
110.0ACHE, TH
210.0MAOB, TH
39.9APOE, APP, MAPT
4
Show member pathways
9.8ACHE, SLC6A3, TH
5
Show member pathways
9.8ACHE, BCHE, SLC6A3
6
Show member pathways
9.6MAOB, SLC18A2, SLC6A3, TH
7
Show member pathways
9.5PARK2, PARK7, SLC6A3, SNCA, SNCAIP
89.2MAOB, PARK2, PARK7, SLC6A3, SNCA, TH
99.1LRRK2, PARK2, PARK7, SLC6A3, SNCA, SNCAIP
10
Show member pathways
8.9LRRK2, PARK2, PARK7, SLC18A2, SLC6A3, SNCA
11
Show member pathways
8.8ACHE, APP, CYP2D6, MAOB, SLC18A2, SLC6A3
128.5APOE, APP, LRRK2, MAPT, PARK2, PARK7
13
Show member pathways
8.5ACHE, ADAMTS2, APP, BCHE, GBA, PARK2

GO Terms for genes affiliated with Dementia, Lewy Body

About this section

Cellular components related to Dementia, Lewy Body according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1nuclear envelope lumenGO:000564110.8APP, BCHE
2inclusion bodyGO:001623410.8LRRK2, SNCA, SNCB
3presynapseGO:009879310.4PARK2, PARK7, SLC6A3
4synaptic vesicleGO:000802110.1LRRK2, SLC18A2, SNCA, SNCAIP, TH
5synapseGO:00452029.8ACHE, APP, LRRK2, SNCA, SNCB
6growth coneGO:00304269.8APP, LRRK2, MAPT, SNCA, SNCB
7terminal boutonGO:00431959.7APP, LRRK2, SLC18A2, SNCA, SNCB, TH
8membrane raftGO:00451219.7APP, LRRK2, PARK7, PRNP, SLC6A3
9neuron projectionGO:00430059.6APP, LRRK2, PARK2, PARK7, SLC6A3, TH
10neuronal cell bodyGO:00430259.5APOE, LRRK2, SLC18A2, SLC6A3, SNCAIP, SNCB
11Golgi apparatusGO:00057949.3ACHE, APOE, APP, LRRK2, PARK2, PRNP
12endoplasmic reticulumGO:00057839.2APOE, BCHE, CYP2D6, LRRK2, PARK2, PARK7
13mitochondrionGO:00057399.2CYP2D6, LRRK2, MAOB, PARK2, PARK7, SNCA
14extracellular spaceGO:00056159.1ACHE, APOE, APP, BCHE, GBA, LRRK2
15axonGO:00304248.8APP, LRRK2, MAPT, PARK7, SLC6A3, SNCA
16membraneGO:00160208.5ACHE, APOE, APP, BCHE, LRRK2, PRNP
17cytoplasmGO:00057377.8APOE, APP, LRRK2, MAPT, PARK2, PARK7

Biological processes related to Dementia, Lewy Body according to GeneCards Suite gene sharing:

(show all 44)
idNameGO IDScoreTop Affiliating Genes
1regulation of synaptic vesicle transportGO:190280310.8LRRK2, PARK2
2axo-dendritic transportGO:000808810.8APP, MAPT
3monoamine transportGO:001584410.7SLC18A2, SLC6A3
4negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayGO:190337710.7PARK2, PARK7
5negative regulation of oxidative stress-induced cell deathGO:190320210.7PARK2, PARK7
6negative regulation of hydrogen peroxide-induced cell deathGO:190320610.7LRRK2, PARK7
7regulation of neuron deathGO:190121410.6LRRK2, SNCA
8virion assemblyGO:001906810.6APOE, RPS27A
9cellular response to dopamineGO:190335110.6LRRK2, PARK2
10cellular copper ion homeostasisGO:000687810.6APP, PRNP
11response to herbicideGO:000963510.5SLC18A2, TH
12protein localization to mitochondrionGO:007058510.5LRRK2, PARK2
13dopamine catabolic processGO:004242010.5MAOB, SLC6A3
14cellular response to manganese ionGO:007128710.5LRRK2, PARK2, TH
15aminergic neurotransmitter loading into synaptic vesicleGO:001584210.5SLC18A2, TH
16cellular response to copper ionGO:007128010.5PRNP, SNCA
17regulation of neurotransmitter secretionGO:004692810.5PARK2, SNCA, SNCAIP
18isoquinoline alkaloid metabolic processGO:003307610.5CYP2D6, TH
19dopamine transportGO:001587210.4SLC18A2, SLC6A3
20dopamine biosynthetic processGO:004241610.4SLC6A3, SNCA, TH
21regulation of dopamine metabolic processGO:004205310.4PARK2, SLC6A3
22negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayGO:190223610.4LRRK2, PARK2, PARK7
23regulation of autophagyGO:001050610.4LRRK2, MAPT, PARK2
24mating behaviorGO:000761710.4APP, TH
25cellular response to oxidative stressGO:003459910.4LRRK2, PARK7, SNCA
26neurotransmitter biosynthetic processGO:004213610.3ACHE, SLC6A3, TH
27response to corticosteroneGO:005141210.3MAOB, SLC18A2, TH
28dopamine uptake involved in synaptic transmissionGO:005158310.3PARK2, PARK7, SLC6A3, SNCA
29regulation of dopamine secretionGO:001405910.3PARK2, SNCA
30mitochondrion organizationGO:000700510.3LRRK2, PARK2, PARK7
31cellular response to drugGO:003569010.2PRNP, SLC18A2, TH
32regulation of locomotionGO:004001210.2LRRK2, SNCA
33adult locomotory behaviorGO:000834410.1APP, PARK2, PARK7, SNCA
34negative regulation of neuron deathGO:190121510.0APOE, LRRK2, PARK2, PARK7, SNCA
35learningGO:000761210.0BCHE, PARK2, TH
36response to cocaineGO:004222010.0SLC18A2, SLC6A3, SNCA
37negative regulation of neuron apoptotic processGO:00435249.9APOE, PARK2, PARK7, SNCA, SNCB
38response to oxidative stressGO:00069799.9APOE, APP, LRRK2, PARK2, PRNP
39cellular protein metabolic processGO:00442679.9APP, PARK2, RPS27A, SNCA, SNCAIP
40negative regulation of protein phosphorylationGO:00019339.9LRRK2, PARK2, PARK7, PRNP, SNCA
41synaptic transmission, dopaminergicGO:00019639.8PARK2, PARK7, SNCA, TH
42dopamine metabolic processGO:00424179.7PARK2, SNCA, SNCAIP, SNCB
43response to drugGO:00424939.2BCHE, MAOB, PARK7, SLC6A3, SNCA, TH
44locomotory behaviorGO:00076269.1APP, PARK2, SLC18A2, SLC6A3, TH

Molecular functions related to Dementia, Lewy Body according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1tau protein bindingGO:004815610.8APOE, SNCA
2monoamine transmembrane transporter activityGO:000850410.7SLC18A2, SLC6A3
3lipoprotein particle bindingGO:007181310.7APOE, MAPT
4acetylcholinesterase activityGO:000399010.6ACHE, BCHE
5cholinesterase activityGO:000410410.6ACHE, BCHE
6phospholipase bindingGO:004327410.6PARK2, SNCA
7ubiquitin-specific protease bindingGO:199038110.5PARK2, PARK7
8tubulin bindingGO:001563110.3LRRK2, PARK2, PRNP
9beta-amyloid bindingGO:000154010.3ACHE, APOE, BCHE
10copper ion bindingGO:000550710.2PARK7, PRNP, SNCA
11dopamine bindingGO:003524010.1SLC6A3, TH
12microtubule bindingGO:000801710.0LRRK2, MAPT, PRNP, SNCA
13drug bindingGO:00081449.5CYP2D6, SLC18A2, SLC6A3
14enzyme bindingGO:00198999.0APP, BCHE, MAPT, PARK2, PARK7, SLC18A2
15identical protein bindingGO:00428028.7APOE, APP, BCHE, LRRK2, PARK2, PARK7

Sources for Dementia, Lewy Body

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet